Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1991-04-09
1993-08-03
Futrovsky, Susan L.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303884, 43524027, C07K 1528, C12N 512
Patent
active
052330249
ABSTRACT:
An anti-idiotypic monoclonal antibody, which induces production of mucoid exopolysaccharide-specific antibodies which are opsonic for mucoid Pseudemonas aeruginosa. The anti-idiotypic monoclonal antibody is produced by a cell line designated C9F5 and having ATCC accession No. HB10715. The anti-idiotypic monoclonal antibody is useful as a vaccine and for diagnostic purposes.
REFERENCES:
patent: 4157389 (1979-06-01), Homma et al.
patent: 4160023 (1979-07-01), Homma et al.
patent: 4285936 (1981-08-01), Pier et al.
patent: 4578458 (1986-03-01), Pier
patent: 4677070 (1987-06-01), Larrick et al.
patent: 4693891 (1987-09-01), Collins et al.
patent: 4834975 (1989-05-01), Siadak et al.
patent: 4834976 (1989-05-01), Rosok et al.
patent: 4918163 (1990-04-01), Young et al.
patent: 4965068 (1990-10-01), Stephan et al.
patent: 4970070 (1990-11-01), Raff
Journal of Experimental Medicine, vol. 160, issued Oct. 1984, K. E. Stein et al., "Neonatal Administration of Idiotype or Antiidiotype Primes for Protection Against Escherichia coli K13 Infection in Mice", pp. 1001-1011, see the entire document.
Schreiber, J. R., et al., "Anti-Idiotype-induced Lipopolysaccharide-specific Antibody Response to Pseudomonas aeruginosa", The Journal of Immunology, pp. 188-193 (Jan. 1, 1991).
Schreiber, J. R., et al., "Anti-Idiotype-Induced, Lipopolysaccharide-Specific Antibody Response to Pseudomonas aeruginosa", Journal of Immunology, vol. 144, pp. 1023-1029 (Feb. 1, 1990).
Pier, G. B., et al., "Opsonophagocytic Killing Antibody to Pseudomonas aeruginosa Mucoid Exopolysaccharide in Older Noncolonized Patients with Cystic Fibrosis", The New England Journal of Medicine, vol. 317, pp. 793-798 (Sep. 24, 1987).
Dressman, G. R. and Kennedy, R. C., "Anti-Idiotypic Antibodies; Implications of Internal Image-Based Vaccines for Infectious Diseases", The Journal of Infectious Diseases, vol. 151, pp. 761-765 (May, 1985).
Westerink, M. A. J., et al., "Development and Characterization of an Anti-Idiotype Antibody to the Capsular Polysaccharide of Neisseria meningitidis Serogroup C", Infection and Immunity, vol. 56, pp. 1120-1127 (May, 1988).
Percival, D. A., et al., "Anti-Idiotypic Antibody-Induced Protection Against Clostridium perfringens Type D", Infection and Immunity, vol. 58, pp. 2487-2492 (Aug., 1990).
Garner, C. V., et al., "Immunogenic Properties of Pseudomonas aeruginosa Mucoid Exopolysaccharide", Infection and Immunity, vol. 58, pp. 1835-1842 (Jun., 1990).
Garner, C. V. and Pier, G. B., "Human Immune Response to Pseudomonas aeruginosa Mucoid Exopolysaccharide Vaccine", Clinical Research, vol. 36, pp. 456A (1988).
Stein, K. E., "Anti-Idiotypes as Bacterial Vaccines", in Biological Applications of Anti-Idiotypes, vol. 2, Bona C. A., Ed. CRC Press, Boca Raton, Fla., pp. 1-11 (1988).
Pier, G. B., et al., "Suppression of the Opsonic-Killing Antibody Response to Pseudomonas aeruginosa Mucoid Exopolysaccharide by Anti-Idiotypic Cytotoxic T Cells", Clinical Research, vol. 38, p. 390A (Apr., 1990).
Schreiber, J. R., et al., "Characteristics of a Pilot Anti-Idiotype Pseudomonas Vaccine; Isotype and Function of Anti-Idiotype-Induced Antibodies", Fourth Annual North American & 1990 International Cystic Fibrosis Conference Abstract, Arlington, Va., Oct. 3-6, 1990.
Baltimore, R. S., Antibiot. Chemotherpy, vol. 36:147-156, 1985.
Cabral, D. A., Pediatric Research, vol. 22(4):429-431, 1987.
Pier Gerald B.
Schreiber John R.
Case Western Reserve University
Futrovsky Susan L.
The Brigham & Women's Hospital
LandOfFree
Anti-idiotypic monoclonal antibodies for mucoid Pseudomonas aeru does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-idiotypic monoclonal antibodies for mucoid Pseudomonas aeru, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-idiotypic monoclonal antibodies for mucoid Pseudomonas aeru will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2271423